Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the Record History.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry v3.4.1 was added to the Record History and the v3.4.0 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe updates introduce UI/display changes such as a glossary toggle, color-coded highlights for changes, and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the record history and the previous v3.3.3 entry was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the Record History. Removed the 'HHS Vulnerability Disclosure' footer link and the older revision 'Revision: v3.3.2' from the page.SummaryDifference0.2%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.